Monday, January 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Fundamental Research to Counter WMD – White Papers Due 1 Feb

by Global Biodefense Staff
January 10, 2017
BAA Broad Agency Announcements

BAA Broad Agency AnnouncementsThe Defense Threat Reduction Agency recently updated its Broad Agency Announcement (BAA) supporting Fundamental Research to Counter Weapons of Mass Destruction.

Issued in March 2015, the BAA is effective through 2024 or until superseded with multiple white paper submission windows. Updates to research funding topics of interest and windows for white paper submissions are issued through Amendments.

The latest Amendment includes the following Basic Research Topics G1-G19:

  • G1: Early Time Signatures of a Nuclear Attack
  • G2: Energy-Efficient Physical and Algorithmic Methods for Detection, Localization, and Isotope Identification
  • G3: Robust Organic Scintillators and Algorithms to Advance Autonomous RN Search
  • G4: Behavior Regime Analysis and Model Order Reduction (MOR) for Nuclear Weapons Effects (NWE)
  • G5: Formation, Evolution, and Conductivity of X-Ray Generated Warm Dense Plasma
  • G6: Modeling Infectious Disease Kinetics and the Host Immune Response
  • G7: Radiation Effects in 3D and Vertically Integrated Microelectronics
  • G8: Dynamic Characterization of Shock Induced Fragmentation and Reactions Involving Reactive Materials upon Impact
  • G9: Evaluating High Strain Rate Mechanical Response and Chemical Reactivity of Energetic/Reactive Composite Materials Produced via Additive Manufacturing
  • G10: Noble Gas Biodetection
  • G11: Critical Requirements for Effective Single-Dose Vaccines
  • G12: Discovery of Novel Methods to Ameliorate the Effects of Nerve Agent Exposure
  • G13: Environmental Factors and the Viable but Non-Culturable State of Francisella tularensis
  • G14: Generating Cross-Reactive Antibodies Following Single-Dose Vaccination
  • G15: Non-Invasive Cell-Free Nucleic Acid for Companion Diagnostics (NICNAC)
  • G16: Novel Technologies to Target Encephalitic Alphavirus Infections
  • G17: Organophosphate Poisoning—Novel Detoxifying Mechanisms in Animal Systems
  • G18: Photonic Transducers for Chemical Threat Sensing
  • G19: Robust and Efficient Catalytic Systems for Degradation of Organophosphorus Nerve Agents

Topics G1-G19 are interested in research projects that span from those that focus on exploratory aspects of a unique problem or a high-risk approach to those that involve a comprehensive program with interdisciplinary areas. Consistent across all proposals should be the focus on innovative research with the potential for high impact to C-WMD science.

DTRA anticipates that the predominance of awards made under Topics G1-G19 will be grants. The pre-application white paper deadline for these topics is 1 February 2017. Further details are available via Solicitation Number: HDTRA1-14-24-FRCWMD-BAA.

Tags: BAAChemical WeaponsDefense Threat Reduction AgencyPOC DiagnosticsRadiation

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC